10-Q Filing

SURGERY PARTNERS, INC. CIK: 1638833 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001638833-19-000038`
Period End Date	20190331
Filing Date	20190510
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	sgry-20190331.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 56 Cash Flow Statement 58 Stockholders Equity 27 Comprehensive Income 10

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$59.90M	USD	Point-in-time
Accumulated depreciation	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$56.10M	USD	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares authorized (shares)	`TemporaryEquitySharesAuthorized`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$142.50M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$184.30M	USD	Point-in-time
Redeemable preferred stock, shares issued (shares)	`TemporaryEquitySharesIssued`	310,000.00	shares	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$307.60M	USD	Point-in-time
Redeemable preferred stock, shares outstanding (shares)	`TemporaryEquitySharesOutstanding`	310,000.00	shares	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$294.90M	USD	Point-in-time
Inventories	`InventoryNet`	$43.80M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$367.80M	USD	Point-in-time
Redeemable preferred stock, redemption value	`RedeemableNoncontrollingInterestEquityPreferredRedemptionValue`	$359.30M	USD	Point-in-time
Inventories	`InventoryNet`	$43.40M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$53.00M	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in USD per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$54.10M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$588.30M	USD	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Preferred stock, shares authorized (shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$535.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $59.9 and $56.1, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$426.30M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $59.9 and $56.1, respectively	`PropertyPlantAndEquipmentNetExcludingCapitalLeasedAssets`	$400.10M	USD	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$54.30M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$54.30M	USD	Point-in-time
Preferred stock, shares outstanding (shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Goodwill	`Goodwill`	$3.39B	USD	Point-in-time
Goodwill	`Goodwill`	$3.38B	USD	Point-in-time
Common stock, par value (in USD per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$78.50M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Investments in and advances to affiliates	`InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures`	$78.50M	USD	Point-in-time
Common stock, shares authorized (shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	49.39M	shares	Point-in-time
Long-term deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$109.20M	USD	Point-in-time
Long-term deferred tax assets	`DeferredTaxAssetsLiabilitiesNetNoncurrent`	$100.90M	USD	Point-in-time
Common stock, shares issued (shares)	`CommonStockSharesIssued`	48.87M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	48.87M	shares	Point-in-time
Common stock, shares outstanding (shares)	`CommonStockSharesOutstanding`	49.39M	shares	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$318.80M	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$36.90M	USD	Point-in-time
Total assets	`Assets`	$4.68B	USD	Point-in-time
Total assets	`Assets`	$4.88B	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$69.70M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$83.30M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$41.00M	USD	Point-in-time
Accrued payroll and benefits	`EmployeeRelatedLiabilitiesCurrent`	$55.20M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$191.80M	USD	Point-in-time
Other current liabilities	`OtherLiabilitiesCurrent`	$155.20M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$57.10M	USD	Point-in-time
Current maturities of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$55.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$359.60M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$349.30M	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.27B	USD	Point-in-time
Long-term debt, less current maturities	`LongTermDebtAndCapitalLeaseObligations`	$2.38B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$370.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$271.30M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$314.60M	USD	Point-in-time
Non-controlling interestsredeemable	`RedeemableNoncontrollingInterestEquityCarryingAmount`	$326.60M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $367.8 and $359.3, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$367.80M	USD	Point-in-time
Redeemable preferred stock - Series A; shares authorized, issued and outstanding - 310,000; redemption value - $367.8 and $359.3, respectively	`TemporaryEquityCarryingAmountAttributableToParent`	$359.30M	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.01 par value; shares authorized - 20,000,000; shares issued or outstanding - none	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,385,974 and 48,869,204, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Common stock, $0.01 par value; shares authorized - 300,000,000; shares issued and outstanding - 49,385,974 and 48,869,204, respectively	`CommonStockValueOutstanding`	$500.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$673.50M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$673.90M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-22.40M	USD	Point-in-time
Accumulated other comprehensive loss	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-33.90M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-247.00M	USD	Point-in-time
Retained deficit	`RetainedEarningsAccumulatedDeficit`	$-249.10M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$404.60M	USD	Point-in-time
Total Surgery Partners, Inc. stockholders' equity	`StockholdersEquity`	$391.40M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$692.90M	USD	Point-in-time
Non-controlling interestsnon-redeemable	`MinorityInterest`	$694.30M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.30B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Total stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.88B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$4.68B	USD	Point-in-time

Income Statement 56 line items

Line Item	Tag	Value	Unit	Period
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$411.30M	USD	1 Quarter
Revenues	`RevenueFromContractWithCustomerIncludingAssessedTax`	$416.80M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$129.20M	USD	1 Quarter
Salaries and benefits	`LaborAndRelatedExpense`	$129.70M	USD	1 Quarter
Supplies	`SuppliesExpense`	$115.00M	USD	1 Quarter
Supplies	`SuppliesExpense`	$114.40M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$35.70M	USD	1 Quarter
Professional and medical fees	`ProfessionalFees`	$35.10M	USD	1 Quarter
Lease expense	`OperatingLeasesRentExpenseNet`	$20.60M	USD	1 Quarter
Lease expense	`OperatingLeasesRentExpenseNet`	$21.40M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$26.20M	USD	1 Quarter
Other operating expenses	`OtherCostAndExpenseOperating`	$26.10M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$326.10M	USD	1 Quarter
Cost of revenues	`CostOfRevenue`	$327.30M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$24.20M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$21.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.80M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$1.90M	USD	1 Quarter
Income from equity investments	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	-	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-600.00K	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$2.00M	USD	1 Quarter
Transaction and integration costs	`BusinessCombinationIntegrationRelatedCosts`	$5.00M	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	$-200.00K	USD	1 Quarter
Other income	`OtherNonrecurringIncomeExpense`	-	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$370.10M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$367.20M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$41.20M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$49.60M	USD	1 Quarter
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	$2.40M	USD	1 Quarter
Tax receivable agreement expense	`TaxReceivableAgreementExpenseBenefit`	-	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-34.30M	USD	1 Quarter
Interest expense, net	`InterestIncomeExpenseNonoperatingNet`	$-42.00M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$6.90M	USD	1 Quarter
Income before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic`	$5.20M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.80M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$1.70M	USD	1 Quarter
Net income	`ProfitLoss`	$3.50M	USD	1 Quarter
Net income	`ProfitLoss`	$5.10M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$23.60M	USD	1 Quarter
Less: Net income attributable to non-controlling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$22.60M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-17.50M	USD	1 Quarter
Net loss attributable to Surgery Partners, Inc.	`NetIncomeLoss`	$-20.10M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$8.50M	USD	1 Quarter
Less: Amounts attributable to participating securities	`UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic`	$7.80M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-25.30M	USD	1 Quarter
Net loss attributable to common stockholders	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-28.60M	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.53	USD	1 Quarter
Basic (in USD per share)	`EarningsPerShareBasic`	$-0.60	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.53	USD	1 Quarter
Diluted (in USD per share)	`EarningsPerShareDiluted`	$-0.60	USD	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.05M	shares	1 Quarter
Basic (shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.01M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.05M	shares	1 Quarter
Diluted (shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.01M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$3.50M	USD	1 Quarter
Net income	`ProfitLoss`	$5.10M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$15.70M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.80M	USD	1 Quarter
Non-cash interest income, net	`NoncashInterestIncomeExpenseNet`	$300.00K	USD	1 Quarter
Non-cash interest income, net	`NoncashInterestIncomeExpenseNet`	$100.00K	USD	1 Quarter
Non-cash lease expense	`AmortizationOfLeasedAsset`	-	USD	1 Quarter
Non-cash lease expense	`AmortizationOfLeasedAsset`	$10.10M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$2.00M	USD	1 Quarter
Equity-based compensation	`ShareBasedCompensation`	$1.90M	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	-	USD	1 Quarter
Loss on disposals and deconsolidations, net	`GainLossOnDispositionOfAssetsAndDeconsolidation`	$-600.00K	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.30M	USD	1 Quarter
Deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$1.40M	USD	1 Quarter
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-300.00K	USD	1 Quarter
Income from equity investments, net of distributions received	`IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions`	$-200.00K	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-14.10M	USD	1 Quarter
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-13.40M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$8.50M	USD	1 Quarter
Other operating assets and liabilities	`IncreaseDecreaseInOtherOperatingCapitalNet`	$29.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$20.50M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$30.00M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$11.80M	USD	1 Quarter
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$10.00M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$25.60M	USD	1 Quarter
Payments for acquisitions, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$7.60M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`PaymentsForProceedsFromProductiveAssets`	$-1.20M	USD	1 Quarter
Proceeds from disposals of facilities and other assets	`PaymentsForProceedsFromProductiveAssets`	-	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$800.00K	USD	1 Quarter
Other investing activities	`PaymentsForProceedsFromOtherInvestingActivities`	$200.00K	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-18.40M	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-36.40M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$16.30M	USD	1 Quarter
Principal payments on long-term debt	`RepaymentsOfLongTermDebt`	$12.90M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$2.40M	USD	1 Quarter
Borrowings of long-term debt	`ProceedsFromIssuanceOfLongTermDebt`	$400.00K	USD	1 Quarter
Payments of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	-	USD	1 Quarter
Payments of preferred dividends	`PaymentsOfDividendsPreferredStockAndPreferenceStock`	$3.90M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$33.80M	USD	1 Quarter
Distributions to non-controlling interest holders	`PaymentsOfDividendsMinorityInterest`	$30.90M	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$-800.00K	USD	1 Quarter
Receipts (payments) related to ownership transactions with non-controlling interest holders	`ProceedsFromPaymentsToMinorityShareholders`	$1.50M	USD	1 Quarter
Repurchase of shares	`PaymentsForRepurchaseOfEquity`	$2.00M	USD	1 Quarter
Repurchase of shares	`PaymentsForRepurchaseOfEquity`	-	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-2.20M	USD	1 Quarter
Other financing activities	`ProceedsFromPaymentsForOtherFinancingActivities`	$-1.10M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-43.90M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-55.70M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-62.10M	USD	1 Quarter
Net decrease in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-41.80M	USD	1 Quarter
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$175.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$113.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.80M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$175.20M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$113.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$184.60M	USD	Point-in-time
Cash, cash equivalents and restricted cash at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$142.80M	USD	Point-in-time

Stockholders Equity 27 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.87M	shares	Point-in-time
Beginning Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	49.39M	shares	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.30B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Beginning Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-4.10M	USD	1 Quarter
Net (loss) income	`NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest`	$-1.60M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$2.00M	USD	1 Quarter
Equity-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$1.90M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$7.80M	USD	1 Quarter
Preferred dividends	`AdjustmentsToAdditionalPaidInCapitalDividendsInExcessOfRetainedEarnings`	$8.50M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-11.50M	USD	1 Quarter
Other comprehensive loss	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	1 Quarter
Cancellation of restricted shares	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$1.00M	USD	1 Quarter
Cancellation of restricted shares	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$700.00K	USD	1 Quarter
Repurchase of shares	`StockRepurchasedAndRetiredDuringPeriodValue`	$2.00M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net (1)	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$14.10M	USD	1 Quarter
Acquisition and disposal of shares of non-controlling interests, net (1)	`NonControllingInterestAcquisitionsAndDisposalsOfInterestsHeldByNonControllingInterestHoldersNet`	$800.00K	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$22.50M	USD	1 Quarter
Distributions to non-controlling interestsnon-redeemable holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$23.50M	USD	1 Quarter
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	48.87M	shares	Point-in-time
Ending Balance, stockholders' equity (shares)	`CommonStockSharesOutstanding`	49.39M	shares	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.30B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.34B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.10B	USD	Point-in-time
Ending Balance, stockholders' equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.08B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$3.50M	USD	1 Quarter
Net income	`ProfitLoss`	$5.10M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	$-11.50M	USD	1 Quarter
Derivative activity	`OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax`	-	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$5.10M	USD	1 Quarter
Comprehensive (loss) income	`ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest`	$-8.00M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$22.60M	USD	1 Quarter
Less: Comprehensive income attributable to non-controlling interests	`ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest`	$23.60M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-31.60M	USD	1 Quarter
Comprehensive loss attributable to Surgery Partners, Inc.	`ComprehensiveIncomeNetOfTax`	$-17.50M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.